ReViral

ReViral

Verified
Biotechnology company that develops and offers antiviral therapies for patients

Launch date
Employees
Market cap
-
Net debt
-
Firm valuation
$525m (Public information from Apr 2022)
Stevenage England (HQ)

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues<1m------
EBITDA(3m)(10m)(10m)(20m)(20m)--
% EBITDA margin(375 %)------
  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/A$1mEarly VC
Not yet verified
$21mSeries A
*
$55mSeries B
$44m
Valuation: $275m
Series C
*
$525m
Valuation: $525m
Acquisition
Total Funding$120m

Recent News about ReViral

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.